Clinical Trials Browser

Phase 1/2 × Advanced Glioblastoma × TIC10 compound × Clear all

NCT02038699 2021-04-30

A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer

Phase 1/2 Withdrawn

BreastCNSGastrointestinalThoracic

Advanced Glioblastoma